We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AstraZeneca and Accent Therapeutics have teamed up to develop cancer therapies using RNA-modifying proteins in a deal potentially worth more than $1 billion for the small Massachusetts-based startup. Read More
The Lancet and the New England Journal of Medicine (NEJM) yesterday retracted separate studies of two different COVID-19 treatments because of concerns over the underlying data provided by the same data analytics company, Surgisphere. Read More
Citing a substantially increased volume of requests for expanded access to investigational drugs to treat COVID-19, the FDA has issued a final guidance that clarifies the conditions under which it will consider sponsor and investigator requests for waivers from full IRB review. Read More
Researchers in the UK are launching a clinical trial to test a unique formulation of ibuprofen for treatment of severe acute respiratory distress syndrome (ARDS) in COVID-19 patients. Read More
Several common cardiovascular drugs are being studied as potential COVID-19 treatments, with early findings suggesting they pose no increased risks for patients taking them regularly. Read More